Ox soralen is a prescription-only medication marketed in pill form that contains methoxsalen as its active ingredient. It belongs to the skin-care therapeutic class and is primarily used as part of psoralen + UVA (PUVA) therapy for certain pigmentary and proliferative skin disorders. In Hong Kong, Ox soralen is regulated under the Pharmacy and Poisons Ordinance and is dispensed only with a medical prescription. Each tablet carries a strength of 10 mg of methoxsalen.
Methoxsalen is a synthetic psoralen-a compound that can intercalate between DNA base pairs. When the skin is subsequently exposed to long-wavelength ultraviolet A (UVA) light, methoxsalen becomes activated and forms covalent bonds with DNA. This process:
Because the drug’s effect depends on UVA exposure, Ox soralen is never taken as a stand-alone oral therapy; it must be paired with a controlled UVA treatment session. The onset of clinical improvement typically appears after several treatment cycles, while the therapeutic effect can persist for weeks to months after stopping therapy.
Ox soralen (methoxsalen) is an approved treatment for the following indications, in accordance with regulatory guidance from the Hong Kong Department of Health and international authorities such as the U.S. FDA:
These uses are based on robust clinical trial data demonstrating efficacy when methoxsalen is administered at appropriate doses and paired with controlled UVA exposure.
Some peer-reviewed studies have explored methoxsalen for additional skin conditions, including:
Disclaimer: These applications are not approved by health-regulatory agencies in Hong Kong. Off-label use should occur only under close supervision of a qualified dermatologist, with individualized risk assessment.
If any of the above conditions apply, a healthcare professional should determine whether Ox soralen is appropriate.
General Advice: Patients should disclose all prescription medicines, over-the-counter drugs, herbal supplements, and vitamins to their prescribing clinician before starting Ox soralen.
Note: Dosing must be individualized by the treating dermatologist based on skin type, disease severity, and response to therapy. The information above reflects the most common regimen for a 10 mg tablet.
Regular follow-up appointments enable early detection of adverse effects and optimisation of therapeutic benefit.
This article provides educational information about Ox soralen and is not a substitute for professional medical advice. Treatment decisions, including the use of Ox soralen for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Methoxsalen’s photochemical action is effective across all Fitzpatrick skin types, but individuals with darker skin may require individualized UVA dosing to achieve optimal repigmentation while minimizing the risk of hyperpigmentation. Dermatologists typically adjust the UVA dose based on the patient’s skin response.
Concurrent use of topical corticosteroids during PUVA therapy is sometimes employed to reduce inflammation and improve outcomes in psoriasis. However, the combination should be prescribed by a dermatologist, as excessive immunosuppression could increase infection risk.
A standard PUVA course consists of 12 to 20 treatment sessions, performed two to three times weekly. The total duration therefore spans approximately 4 to 8 weeks, depending on patient response and tolerability.
Patients traveling to sunny destinations should avoid unprotected sunlight on treated skin for at least 24 hours after each dose. Wearing broad-spectrum sunscreen (SPF 30 or higher) and protective clothing is advisable even when indoors near windows.
Baseline liver function tests are recommended before initiating therapy, followed by periodic monitoring (e.g., every 3-6 months) during prolonged treatment, especially in patients with pre-existing hepatic conditions.
Long-term exposure to methoxsalen-enhanced UVA can increase the risk of cataract formation and conjunctival alterations. Regular ophthalmologic check-ups are essential to detect early changes and intervene promptly.
No. Ox soralen is classified as a prescription-only medication under Hong Kong’s Pharmacy and Poisons Ordinance and must be dispensed by a licensed pharmacist upon presentation of a valid prescription.
If a UVA session is cancelled, the associated methoxsalen dose should be omitted. Do not take an extra tablet later to “make up” for the missed dose, as this could increase the risk of phototoxicity.
There are no strict dietary prohibitions, but patients should limit excessive alcohol intake, which can stress liver metabolism and exacerbate gastrointestinal side effects.
Both therapies aim to treat psoriasis and vitiligo, but PUVA (Ox soralen + UVA) often achieves faster repigmentation in vitiligo and may be more effective for extensive plaque psoriasis. Narrow-band UVB avoids systemic photosensitisation and is preferred for patients who cannot tolerate oral psoralens. The choice depends on disease severity, patient preference, and physician assessment.
